Preparing for the unexpected: special considerations and complications after sugammadex administration

about

Preparing for the unexpected: special considerations and complications after sugammadex administration

Item

http://www.wikidata.org/entity/Q42682587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Preparing for the unexpected: ...... fter sugammadex administration

@en

Preparing for the unexpected: ...... fter sugammadex administration

@nl

type

Item

label

Preparing for the unexpected: ...... fter sugammadex administration

@en

Preparing for the unexpected: ...... fter sugammadex administration

@nl

prefLabel

Preparing for the unexpected: ...... fter sugammadex administration

@en

Preparing for the unexpected: ...... fter sugammadex administration

@nl

P1476

Preparing for the unexpected: ...... fter sugammadex administration

@en

P2093

J Ross Renew

http://www.w3.org/2001/XMLSchema#string

Takayuki Kunisawa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour

Hypersensitivity associated with sugammadex administration: a systematic review

A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex

Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome.

Residual paralysis after emergence from anesthesia.

Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block.

Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.

Three suspected cases of sugammadex-induced anaphylactic shock.

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.

P2888

s12871-017-0429-9

P304

140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12871-017-0429-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sorin J Brull

Hajime Iwasaki

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092249027

http://www.w3.org/2001/XMLSchema#string

P698

29041919

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

polycyclic compound

biomedical investigative technique

P932

5645926

http://www.w3.org/2001/XMLSchema#string